✦ LIBER ✦

Interferon-ribavirin combination therapy for chronic hepatitis C

✍ Scribed by Solko W. Schalm; J. T. Brouwer; L. Chemello; A. Alberti; A. Bellobuono; G. Ideo; R. Schwartz; O. Weiland

Publisher: Springer US
Year: 1996
Tongue: English
Weight: 466 KB
Volume: 41
Category: Article
ISSN: 0163-2116
DOI: 10.1007/bf02087889

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a

Adequate timing of ribavirin reduction i

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Ma 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 171 KB

Factors contributing to ribavirin dose r

Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C

✍ Shintaro Takaki; Akihito Tsubota; Tetsuya Hosaka; Norio Akuta; Takashi Someya; M 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 209 KB

Efficacy of re-treatment with pegylated

Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

✍ Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide O 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 297 KB

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

✍ Norio Horiike; Morikazu Onji 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 132 KB

Retreatment of patients with chronic hep

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine

✍ Rudolf E Stauber; Harald Hofer; Franz Hackl; Kurt Schüze; Christian Datz; Karin 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 738 KB